Sequential drain amylase to guide drain removal following pancreatectomy

dc.contributor.authorVillafane-Ferriol, N.
dc.contributor.authorVan Buren, G.
dc.contributor.authorMendez-Reyes, J.E.
dc.contributor.authorMcElhany, A.L.
dc.contributor.authorMassarweh, N.N.
dc.contributor.authorSilberfein, E.
dc.contributor.authorHsu, C.
dc.contributor.authorTran Cao, H.S.
dc.contributor.authorSchmidt, C.
dc.contributor.authorZyromski, N.
dc.contributor.authorDillhoff, M.
dc.contributor.authorRoch, A.
dc.contributor.authorOliva, E.
dc.contributor.authorSmith, A.C.
dc.contributor.authorZhang, Q.
dc.contributor.authorFisher, W.E.
dc.contributor.departmentSurgery, School of Medicineen_US
dc.date.accessioned2019-08-26T16:32:12Z
dc.date.available2019-08-26T16:32:12Z
dc.date.issued2018-06
dc.description.abstractBACKGROUND: Although used as criterion for early drain removal, postoperative day (POD) 1 drain fluid amylase (DFA) ≤ 5000 U/L has low negative predictive value for clinically relevant postoperative pancreatic fistula (CR-POPF). It was hypothesized that POD3 DFA ≤ 350 could provide further information to guide early drain removal. METHODS: Data from a pancreas surgery consortium database for pancreatoduodenectomy and distal pancreatectomy patients were analyzed retrospectively. Those patients without drains or POD 1 and 3 DFA data were excluded. Patients with POD1 DFA ≤ 5000 were divided into groups based on POD3 DFA: Group A (≤350) and Group B (>350). Operative characteristics and 60-day outcomes were compared using chi-square test. RESULTS: Among 687 patients in the database, all data were available for 380. Fifty-five (14.5%) had a POD1 DFA > 5000. Among 325 with POD1 DFA ≤ 5000, 254 (78.2%) were in Group A and 71 (21.8%) in Group B. Complications (35 (49.3%) vs 87 (34.4%); p = 0.021) and CR-POPF (13 (18.3%) vs 10 (3.9%); p < 0.001) were more frequent in Group B. CONCLUSIONS: In patients with POD1 DFA ≤ 5000, POD3 DFA ≤ 350 may be a practical test to guide safe early drain removal. Further prospective testing may be useful.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationVillafane-Ferriol, N., Van Buren, G., 2nd, Mendez-Reyes, J. E., McElhany, A. L., Massarweh, N. N., Silberfein, E. J., … Fisher, W. E. (2018). Sequential drain amylase to guide drain removal following pancreatectomy. HPB : the official journal of the International Hepato Pancreato Biliary Association, 20(6), 514–520. doi:10.1016/j.hpb.2017.11.008en_US
dc.identifier.urihttps://hdl.handle.net/1805/20574
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.hpb.2017.11.008en_US
dc.relation.journalHPB : the official journal of the International Hepato Pancreato Biliary Associationen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectAmylasesen_US
dc.subjectBiomarkersen_US
dc.subjectClinical enzyme testsen_US
dc.subjectDevice removalen_US
dc.subjectDrainageen_US
dc.subjectPancreatectomyen_US
dc.subjectPancreatic Fistulaen_US
dc.subjectPancreaticoduodenectomyen_US
dc.titleSequential drain amylase to guide drain removal following pancreatectomyen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
nihms936015.pdf
Size:
190.43 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: